Master in Nuclear Engineering
Dr. E. D'Agostino obtained his master in Nuclear Engineering from the Politecnico di Milano, Italy, in 2001. After being selected to participate to the T.I.M.E. (Top Industrial Manager for Europe) program, he spent two years at the Ecole Polytechnique of the Universite Libre de Brussel, where he received a Master in Physics Engineering, also in 2001. In 2001, he started his PhD at the KU Leuven, within the Medical Image Computing laboratory, under the supervision of Professor Paul Suetens, in the field of medical image analysis. He obtained his PhD in 2006. After his PhD graduation, Dr. D'Agostino worked one year as post-doctoral fellow at the Medical Imaging Research Center, KU Leuven, where he was internal coordinator of the research projects funded by the IBBT (Instituut voor Breed Band Technologie). In 2007 he left KU Leuven and worked for 6 months at IMEC, within the unit of Business Development, on a feasibility project of a new technology for medical imaging. In march 2008 he joined the Belgian Nuclear Research Center, where he worked as a research scientist within the groups of Dosimetry and Radiation Protection and of Radiobiology. During his period at the Belgian Nuclear Research Center, his research interests were focused on charged particle therapy (hadrontherapy) and on the development of new instrumentation for measuring the dose absorbed by patients undergoing radiation therapy. He currently supervises and/or co-supervises 5 PhD students.
Dr. D'Agostino has served as reviewer for the major journal in the field on medical imaging, including, Medical Image Analysis, IEEE Transaction on Medical Imaging and Neuroimage. He was also selected, in 2005 and 2007, as expert by the European Commission for the review of project proposals submitted with the FP7-Health program. He was full member of the European Dosimetry Association (EURADOS), where he was part the working group on (radiotherapy) patients dosimetry. Reviewer experience for different major journals in the field of medical imaging.
In March 2013 Dr. D’Agostino founded DoseVue NV, in collaboration with the Belgian Nuclear Research Center. The scope of DoseVue NV is the development of innovative technology for in-vivo dosimetry.